Healthcare Professional’s Guide to FABHALTA for C3G indication
This brochure has been developed by Novartis Pharmaceuticals UK Ltd to support healthcare professionals prescribing iptacopan for C3G. The brochure aims to provide guidance and mitigate the possible risk of infections during iptacopan treatment